Hunter Beach 4%

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Hunter Beach 4%
Generic name: LIDOCAINE
Manufacturer: HUNTERS BEACH LIFE
Product type: HUMAN OTC DRUG
SPL set ID: f2ef9c12-6e42-486b-b6f2-0ad534e94294
SPL ID: 415e0e09-6248-4fea-8f54-b3cb6b9bb5ce
Version: 2
Effective date: 2024-12-18
Source export date: 2026-10-12
Source partition: 9
Source file: https://download.open.fda.gov/drug/label/drug-label-0009-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/fb14b8f3d34b45230a84f851c029385f512adf3f002423a9b78d4f7ca626ecec/drug-label-0009-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 02:25:51

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Hunter Beach 4%	openfda.brand_name
generic name		LIDOCAINE	openfda.generic_name
manufacturer name		HUNTERS BEACH LIFE	openfda.manufacturer_name
ndc	package	82517-002-04	openfda.package_ndc
ndc	product	82517-002	openfda.product_ndc
ndc11	package	82517000204	derived:openfda.package_ndc
rxcui		1291672	openfda.rxcui
spl id		415e0e09-6248-4fea-8f54-b3cb6b9bb5ce	id
spl set id		f2ef9c12-6e42-486b-b6f2-0ad534e94294	set_id
unii		98PI200987	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Do not use in large quantities, particularly over raw surfaces or areas with blisters. When using this product avoid contact with eyes. Use only as directed. Intentional misuse by deliberate concentrating and inhaling the contents can be harmful or fatal. Stop use and consult a doctor if condition worsens, or symptoms last more than 7 days. Symptoms clear up and occur again within a few days. Keep out of the reach of children . If swallowed get medical help or contact a Poison Control Center right away

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.